Immunovia engages in the development of a technology platform based on antibody microarray analysis. It focuses on developing diagnosis of cancer and autoimmune diseases. The Company offers IMMray PanCan-d, a blood-based test for the detection of pancreatic cancer. It also provides IMMray Proteome Survey platform, a discovery tool for proteome scanning.
Market capitalization (26-Feb-2021)
Closing stock price (26-Feb-2021)
Immunovia has 609 Twitter Followers. The number of followers has increased 1.5% month over month and increased 5.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Immunovia founded?
Immunovia was founded in 2007.
Who are Immunovia key executives?
Immunovia's key executives are Rolf Ehrnström, Mimmi Ekberg and Carl Borrebaeck.
How many employees does Immunovia have?
Immunovia has 67 employees.
Who are Immunovia competitors?
Competitors of Immunovia include Anixa Biosciences, Prime Genomics and Predicine.
Where is Immunovia headquarters?
Immunovia headquarters is located at Medicon Village Scheelevägen 2, Lund.
Where are Immunovia offices?
Immunovia has offices in Lund, Marlborough and Frankfurt am Main.
How many offices does Immunovia have?
Immunovia has 4 offices.
Receive alerts for 300+ data fields across thousands of companies